Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Deferred Taxes: 2009-2025

Historic Deferred Taxes for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to -$51.1 million.

  • BIO-TECHNE's Deferred Taxes rose 198.78% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.5 million, marking a year-over-year decrease of 21.98%. This contributed to the annual value of -$51.1 million for FY2025, which is 29.56% down from last year.
  • Per BIO-TECHNE's latest filing, its Deferred Taxes stood at -$51.1 million for FY2025, which was down 29.56% from -$39.4 million recorded in FY2024.
  • Over the past 5 years, BIO-TECHNE's Deferred Taxes peaked at $6.8 million during FY2022, and registered a low of -$51.1 million during FY2025.
  • Moreover, its 3-year median value for Deferred Taxes was -$39.4 million (2024), whereas its average is -$40.0 million.
  • Its Deferred Taxes has fluctuated over the past 5 years, first spiked by 124.85% in 2022, then tumbled by 533.79% in 2023.
  • Yearly analysis of 5 years shows BIO-TECHNE's Deferred Taxes stood at -$27.4 million in 2021, then spiked by 124.85% to $6.8 million in 2022, then plummeted by 533.79% to -$29.6 million in 2023, then slumped by 33.42% to -$39.4 million in 2024, then fell by 29.56% to -$51.1 million in 2025.